MUC5B启动子多态性与端粒长度在慢性过敏性肺炎患者中的研究
该观察性队列对照研究纳入两个独立慢性过敏性肺炎队列(UCSF 145例,UTSW 72例),检测IPF相关SNP(MUC5B rs35705950、TOLLIP rs5743890)及外周血白细胞端粒长度。发现MUC5B次要等位基因频率显著高于健康对照,且与影像纤维化范围及生存降低相关,提示与IPF共享病理生物学。
要点
- 慢性过敏性肺炎患者MUC5B rs35705950次要等位基因频率显著高于健康对照。
- 端粒长度短于年龄第10百分位与生存降低显著相关。
核心结论
- MUC5B rs35705950与短端粒长度和慢性过敏性肺炎纤维化范围、UIP病理特征及生存降低相关,提示与IPF共享病理生物学,可能有助于风险分层。
研究设计与样本
- 观察性队列对照研究,纳入两个独立慢性过敏性肺炎队列:UCSF 145例和UTSW 72例。
- 检测MUC5B rs35705950、TOLLIP rs5743890及外周血白细胞端粒长度,并与IPF队列及健康对照比较。
主要发现
- TOLLIP rs5743890次要等位基因频率在慢性过敏性肺炎与健康对照间无显著差异。
临床怎么用
- 对慢性过敏性肺炎患者可考虑检测MUC5B rs35705950和端粒长度以辅助纤维化风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with hypersensitivity pneumonitis are at risk of developing pulmonary fibrosis, which is associated with reduced survival. In families with multiple affected members, individuals might be diagnosed as having idiopathic pulmonary fibrosis (IPF) or chronic (fibrotic) hypersensitivity pneumonitis, which suggests these disorders share risk factors. We aimed to test whether the genomic risk factors associated with the development and progression of IPF are also associated with the development of fibrosis and reduced survival in people with chronic hypersensitivity pneumonitis. METHODS: We did an observational study of two independent cohorts of patients with chronic hypersensitivity pneumonitis, one from the University of California San Francisco, CA, USA (UCSF), and one from the University of Texas Southwestern, TX, USA (UTSW). We measured two common single-nucleotide polymorphisms associated with IPF (MUC5B rs35705950 and TOLLIP rs5743890) and telomere length in peripheral blood leucocytes, and assessed their associations with chronic hypersensitivity pneumonitis risk, survival, and clinical, radiographic, and pathological features. We compared findings with those in patients with IPF from the UCSF and UTSW cohorts, and healthy controls from the European population of the 1000 Genomes Project Phase 3, version 1. FINDINGS: The cohorts included 145 patients from UCSF and 72 from UTSW. The minor allele frequency (MAF) was greater for MUC5B rs35705950 in patients with chronic hypersensitivity pneumonitis than in healthy controls (24·4% in UCSF and 32·3% in UTSW vs 10·7%, both p<0·0001), but not for TOLLIP rs5743890. The MAFs were similar to those for IPF (UCSF 33·3%, p=0·09; UTSW 32·0%, p=0·95). In the combined UCSF and UTSW chronic hypersensitivity pneumonitis cohort, we saw associations between extent of radiographic fibrosis and MUC5B rs35705950 minor alleles (adjusted odds ratio [OR] 1·91, 95% CI 1·02-3·59, p=0·045) and short telomere length (adjusted OR per unit change in mean natural logarithm-transformed ratio of telomere repeat copy number to single gene copy number 0·23, 0·09-0·59, p=0·002). Telomere length less than the tenth percentile for age was also significantly associated with reduced survival (log-rank p=0·006). INTERPRETATION: The associations between MUC5B rs35705950 and short telomere length with extent of fibrosis, histopathological features of usual interstitial pneumonia, and reduced survival in patients with chronic hypersensitivity pneumonitis suggest shared pathobiology with IPF, and might help to stratify risk. FUNDING: National Institutes of Health and Nina Ireland Program for Lung Health.
引用
- Ley B, Newton CA, Arnould I, et al. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study. Lancet Respir Med. 2017. PMID: 28648751. doi:10.1016/S2213-2600(17)30216-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。